(2-氯-3,4-二甲氧基苯基)甲醇 | 93983-13-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (2-氯-3,4-二甲氧基苯基)甲醇
• 英文名称: 2-chloro-3,4-dimethoxybenzyl alcohol
• 英文别名: 2-chloro-3,4-dimethoxybenzylalcohol；2-chloroveratryl alcohol；[2-chloro-3,4-bis(methyloxy)phenyl]methanol；(2-Chloro-3,4-dimethoxyphenyl)methanol
• CAS: 93983-13-2
• 化学式: C₉H₁₁ClO₃
• 分子量: 202.638
• InChiKey: ZXYBQLFOEYWYBM-UHFFFAOYSA-N

物化性质

• 熔点：
  70-72℃
• 沸点：
  307.6±37.0 °C(Predicted)
• 密度：
  1.241±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2909499000

SDS

Name:	(2-Chloro-3 4-dimethoxyphenyl)methanol 97% Material Safety Data Sheet
Synonym:
CAS:	93983-13-2

Section 1 - Chemical Product MSDS Name:(2-Chloro-3 4-dimethoxyphenyl)methanol 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
93983-13-2	(2-Chloro-3,4-dimethoxyphenyl)methanol	97%	301-301-2

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Air sensitive.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store under nitrogen.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 93983-13-2: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 70 - 71 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: Not available.
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H11ClO3
Molecular Weight: 203

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to air.
Incompatibilities with Other Materials:
Oxidizing agents, acid chlorides, halogens, halogenated agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide, acrid smoke and fumes.
Hazardous Polymerization: Has not been reported.

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 93983-13-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(2-Chloro-3,4-dimethoxyphenyl)methanol - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 93983-13-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 93983-13-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 93983-13-2 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (2-氯-3,4-二甲氧基苯基)甲醇 在 三溴化磷 作用下， 以 二氯甲烷 为溶剂， 反应 0.75h， 生成 1-(溴甲基)-2-氯-3,4-二(甲氧基)苯
  参考文献：
  名称：

  吡啶并哒嗪-6一p38αMAP激酶抑制剂的合成及生物学活性。第2部分

  摘要：

  该手稿总结了哒嗪酮支架上的结构活性关系（SAR），并鉴定了在大鼠关节炎功效模型中具有亚纳摩尔p38α活性和24 h覆盖范围的化合物。

  DOI：

  10.1016/j.bmcl.2012.07.035
• 作为产物：
  描述：

  异香兰素 在 sodium tetrahydroborate 、 氯 、 potassium carbonate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.08h， 生成 (2-氯-3,4-二甲氧基苯基)甲醇
  参考文献：
  名称：

  多巴胺激动剂1-芳基-2,3,4,5-四氢-1H-3-苯并ze庚因-7,8-二醇的合成及其肾脏血管舒张活性：非诺多old的卤素和甲基类似物。

  摘要：

  发现某些6-卤代-1-苯基-2,3,4,5-四氢-1H-3-苯并ze庚因是有效的D-1多巴胺激动剂。1-（4-羟苯基）类似物不具有中枢神经系统活性，因为它们的高极性抑制了其进入大脑。但是，这些化合物是有效的肾血管扩张药。非氯多巴，6-氯类似物，是该系列中特别重要的成员，其合成，药理和临床特性已得到广泛研究。6-甲基和6-碘同系物是有效的肾血管扩张剂，但通过刺激大鼠尾状腺苷酸环化酶测定，非有效的部分D-1激动剂。可能的合理化建议这些活动具有不同的受体储备。9位取代的苯并庚因多巴胺激动剂不活跃或效力低下，

  DOI：

  10.1021/jm00161a029

文献信息

• Synthesis and biological activity of pyridopyridazin-6-one p38α MAP kinase inhibitors. Part 2
  作者：Robert M. Tynebor、Meng-Hsin Chen、Swaminathan R. Natarajan、Edward A. O’Neill、James E. Thompson、Catherine E. Fitzgerald、Stephen J. O’Keefe、James B. Doherty

  DOI：10.1016/j.bmcl.2012.07.035

  日期：2012.9

  This manuscript concludes the Structure Activity Relationship (SAR) on the pyridazinone scaffold and identifies a compound with subnanomolar p38α activity and 24 h coverage in the rat arthritis efficacy model.

  该手稿总结了哒嗪酮支架上的结构活性关系（SAR），并鉴定了在大鼠关节炎功效模型中具有亚纳摩尔p38α活性和24 h覆盖范围的化合物。
• Heterocyclic compounds
  申请人：Yamada Tatsuhiro

  公开号：US20050250796A1

  公开（公告）日：2005-11-10

  The inventive subject matter relates to compounds, pharmaceutical compositions, and kits containing a heterocyclic compound represented by the formula (I) wherein R is an alkyl group optionally having substituent(s) etc., X is an amino group optionally having substituent(s), Y 1 and Y 2 are nitrogen atoms etc., an isomer or solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient.

  这项创新主题涉及包含由式（I）表示的杂环化合物的化合物、药物组合物和试剂盒，其中R是一个烷基基团，可选择地具有取代基等，X是一个氨基基团，可选择地具有取代基等，Y1和Y2是氮原子等，其异构体或溶剂化合物或其药用可接受盐作为活性成分。
• New Derivatives of 3,4-Dihydroisoquinoline-3-carboxylic Acid with Free-Radical Scavenging, D-Amino Acid Oxidase, Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activity
  作者：Jolanta Solecka、Adam Guśpiel、Magdalena Postek、Joanna Ziemska、Robert Kawęcki、Katarzyna Łęczycka、Agnieszka Osior、Bartłomiej Pietrzak、Krzysztof Pypowski、Agata Wyrzykowska

  DOI：10.3390/molecules191015866

  日期：——

  A series of 3,4-dihydroisoquinoline-3-carboxylic acid derivatives were synthesised and tested for their free-radical scavenging activity using 2,2-diphenyl-1-picrylhydrazyl radical (DPPH·), 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical (ABTS·+), superoxide anion radical (O2·−) and nitric oxide radical (·NO) assays. We also studied D-amino acid oxidase (DAAO), acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity. Almost each of newly synthesised compounds exhibited radical scavenging capabilities. Moreover, several compounds showed moderate inhibitory activities against DAAO, AChE and BuChE. Compounds with significant free-radical scavenging activity may be potential candidates for therapeutics used in oxidative-stress-related diseases.

  合成了一系列3,4-二氢异喹啉-3-羧酸衍生物，并使用2,2-二苯基-1-苦味肼自由基（DPPH·）、2,2'-联吡啶双（3-乙基苯噻唑啉-6-磺酸）自由基（ABTS·+）、超氧阴离子自由基（O2·−）和一氧化氮自由基（·NO）进行自由基清除活性测试。我们还研究了D-氨基酸氧化酶（DAAO）、乙酰胆碱酯酶（AChE）和丁酰胆碱酯酶（BuChE）的抑制活性。几乎每一种新合成的化合物都表现出了清除自由基的能力。此外，几种化合物对DAAO、AChE和BuChE表现出了中等的抑制活性。具有显著自由基清除活性的化合物可能是用于氧化应激相关疾病治疗的潜在候选药物。
• SUBSTITUTED IMIDAZOLES
  申请人：CHUBB NATHAN ANTHONY LOGAN

  公开号：US20070167506A1

  公开（公告）日：2007-07-19

  This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

  本发明涉及一系列α取代的2-苄基取代咪唑化合物及其药用可接受盐和溶剂化合物，包括这些化合物的组合物、合成过程以及它们作为驱虫剂的用途。
• 2-Aminopurine analogs having HSP90-inhibiting activity
  申请人：Kasibhatla Rao Srinivas

  公开号：US20050113340A1

  公开（公告）日：2005-05-26

  2-Aminopurine analogs are described and demonstrated or predicted to have utility as Heat Shock Protein 90 (HSP90) inhibiting agents in the treatment and prevention of various HSP90 mediated disorders, e.g., proliferative disorders. Method of synthesis and use of such compounds are also described and claimed.

  本文描述了2-氨基嘌呤类似物，并展示或预测其作为热休克蛋白90（HSP90）抑制剂，在治疗和预防各种HSP90介导的疾病，例如增殖性疾病方面具有实用性。还描述和声明了这些化合物的合成方法和使用方法。